Effects of Epidermal Growth Factor and Estrogen on the Regulation of the HMG-I/Y Gene in Human Mammary Epithelial Cell Lines
- 1 November 1997
- journal article
- research article
- Published by Mary Ann Liebert Inc in DNA and Cell Biology
- Vol. 16 (11) , 1299-1309
- https://doi.org/10.1089/dna.1997.16.1299
Abstract
Members of the HMG-I/Y family of high-mobility-group chromatin proteins have been demonstrated to regulate gene expression in human cells in vivo. They are thought to function as gene regulatory molecules by acting as architectural transcription factors that modulate DNA and/or chromatin structure. Numerous studies have indicated that elevated HMG-I/Y gene expression is directly correlated with more advanced cancers and with increased metastatic potential. The inducible expression of the HMG-I/Y gene was studied in two human mammary epithelial cell lines, MCF7 and Hs578T, in the presence, or absence, of either 17βdiol or epidermal growth factor (EGF). Northern blot analysis indicated that there was no increase in HMG-I/Y mRNA in the nonmetastatic MCF7 cells when they were treated with either 17βestradiol or EGF. In contrast, in the highly metastatic Hs578T cell line, there is a dramatic induction of HMG-I/Y mRNA expression of up to 23-fold when the cells are treated with EGF. mRNA primer extension analysis indicated that only two (of the possible four different) transcription initiation start sites in the HMG-I/Y gene are induced by EGF treatment of the Hs578T cells. Additional experiments demonstrated that in both epithelial cell types HMG-I/Y mRNAs are very stable (tl/2 of ~30 hr) and that in the Hs578T cells treated with EGF the cellular concentrations of the HMG-I/Y proteins increase concurrently with the induced mRNA levels. Given that HMG-I/Y proteins are regulators of gene activity whose elevated in vivo concentrations are known to be correlated with increased metastatic potential, these data demonstrating an EGF-induced over-expression of HMG-I/Y in the highly metastatic Hs578T, but not in the nonmetastatic MCF7cells, may have important implications concerning the cellular mechanisms involved in the progression of mammary epithelial tumors.Keywords
This publication has 35 references indexed in Scilit:
- Ten Pulmonary Chondroid Hamartomas With Chromosome 6p21 Breakpoints Within the HMG-I(Y) Gene or Its Immediate SurroundingsJNCI Journal of the National Cancer Institute, 1996
- The invasive and metastatic properties of hormone-independent but hormone-responsive variants of MCF-7 human breast cancer cellsClinical & Experimental Metastasis, 1993
- Sequence-specific binding of HMG-I(Y) to the proximal promoter of the gp91-phox geneBiochemical and Biophysical Research Communications, 1992
- The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patientsEndocrine Reviews, 1992
- Measurement of occupied and non-occupied epidermal growth factor receptor sites in 216 human breast cancer biopsiesBreast Cancer Research and Treatment, 1991
- Epidermal growth factor receptor expression as a prognostic indicator in breast cancerEuropean Journal of Cancer and Clinical Oncology, 1991
- Comparison of multiple forms of the high mobility group I proteins in rodent and human cellsEuropean Journal of Biochemistry, 1991
- Expression of mRNAs encoding mammalian chromosomal proteins HMG-I and HMG-Y during cellular proliferationExperimental Cell Research, 1990
- High-mobility group protein HMG-I localizes to G/Q- and C-bands of human and mouse chromosomes.The Journal of cell biology, 1989
- On the phosphorylation of low molecular mass HMG (high mobility group) proteins in Ehrlich ascites cellsFEBS Letters, 1985